First_id	PMID	Gene	Diff_nonres_res	PValue	Minus_log10_PValue	Original_Dataset	Cancer_Type	Regimen	Num_Responders	Num_NonResponders	Source	ImmunEscpMap_ID
1	25765070	C1QC	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
2	25765070	ARID1A	5.3	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
3	25765070	KRAS	-28.1	0.0975	1.01099538430146	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
4	25765070	TSC22D1	9.1	0.529	0.276544327964814	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
5	25765070	MAX	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
6	25765070	TP53	-9.1	0.724	0.140261433802853	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
7	25765070	LRP1B	-1.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
8	25765070	GNAS	-7.6	0.602	0.220403508742175	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
9	25765070	HLA-DRB5	18.2	0.273	0.563837352959244	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
10	25765070	HLA-B	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
11	25765070	NOTCH3	13.6	0.537	0.270025714300444	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
12	25765070	SBSN	5.3	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
13	25765070	TGFB1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
14	25765070	MUC4	-21.2	0.297	0.527243550682788	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
15	25765070	ID4	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
16	25765070	COL11A1	-20.5	0.115	0.939302159646388	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
17	25765070	PIK3C2B	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
18	25765070	MMP2	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
19	25765070	COL6A2	-25	0.0368	1.43415218132648	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
20	25765070	SREBF2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
21	25765070	STAB1	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
22	25765070	SHOX2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
23	25765070	EGF	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
24	25765070	NOTCH1	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
25	25765070	ANK3	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
26	25765070	OLR1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
27	25765070	HNF1A	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
28	25765070	NOS2	9.1	0.529	0.276544327964814	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
29	25765070	KEAP1	-15.9	0.319	0.496209316942819	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
30	25765070	MYCN	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
31	25765070	POLQ	0.799999999999999	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
32	25765070	PDGFRA	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
33	25765070	ROS1	0.799999999999999	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
34	25765070	SMG1	-25	0.0368	1.43415218132648	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
35	25765070	ITGB3	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
36	25765070	MAP4K1	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
37	25765070	PTPRT	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
38	25765070	CD80	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
39	25765070	PPP3CA	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
40	25765070	APC	-7.6	0.602	0.220403508742175	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
41	25765070	SREBF1	13.6	0.537	0.270025714300444	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
42	25765070	MIF	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
43	25765070	CD47	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
44	25765070	COL6A6	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
45	25765070	SQSTM1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
46	25765070	FOLH1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
47	25765070	LGALS9	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
48	25765070	STK11	-15.9	0.319	0.496209316942819	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
49	25765070	COL6A3	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
50	25765070	VCAN	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
51	25765070	STC2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
52	25765070	CEMIP	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
53	25765070	GPM6A	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
54	25765070	HLA-DRB1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
55	25765070	AGRN	5.3	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
56	25765070	METTL3	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
57	25765070	DLL3	5.3	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
58	25765070	CXCR3	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
59	25765070	NOTCH2	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
60	25765070	ZEB1	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
61	25765070	ALOX5	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
62	25765070	DGKZ	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
63	25765070	PIK3R2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
64	25765070	FN1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
65	25765070	TERT	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
66	25765070	HSPA4	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
67	25765070	HGF	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
68	25765070	FABP4	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
69	25765070	NFX1	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
70	25765070	ATRX	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
71	25765070	SLC6A8	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
72	25765070	PIK3CD	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
73	25765070	FASN	-15.9	0.319	0.496209316942819	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
74	25765070	POU5F1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
75	25765070	SERPINE1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
76	25765070	LGALS8	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
77	25765070	PANX1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
78	25765070	IL1A	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
79	25765070	NR0B1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
80	25765070	EPHA2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
81	25765070	FOS	9.1	0.529	0.276544327964814	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
82	25765070	MYBL2	-7.6	0.602	0.220403508742175	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
83	25765070	PIK3CA	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
84	25765070	PDLIM7	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
85	25765070	GPER1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
86	25765070	KMT2C	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
87	25765070	WNT9A	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
88	25765070	COL2A1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
89	25765070	BRD4	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
90	25765070	LOX	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
91	25765070	UBR5	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
92	25765070	HAS2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
93	25765070	AR	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
94	25765070	MAP3K11	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
95	25765070	COL6A1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
96	25765070	EHMT2	-12.2	0.279	0.554395796726402	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
97	25765070	DDR1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
98	25765070	EGFR	9.1	0.529	0.276544327964814	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
99	25765070	ITGB4	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
100	25765070	CSF1R	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
101	25765070	SMARCA2	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
102	25765070	MRGPRX3	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
103	25765070	CD276	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
104	25765070	ITGAE	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
105	25765070	IGF2R	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
106	25765070	TLR2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
107	25765070	TAPBP	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
108	25765070	PCSK9	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
109	25765070	ITGB1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
110	25765070	SH3PXD2A	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
111	25765070	CCL17	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
112	25765070	IRF8	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
113	25765070	ROCK1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
114	25765070	IL11	0.799999999999999	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
115	25765070	CXCR4	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
116	25765070	PIKFYVE	-16.7	0.118	0.928117992693875	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
117	25765070	PIK3CB	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
118	25765070	SLIT2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
119	25765070	IGFBP7	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
120	25765070	EDN1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
121	25765070	JAK2	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
122	25765070	PTGES2	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
123	25765070	MAOA	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
124	25765070	CD93	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
125	25765070	COTL1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
126	25765070	ITGA4	-3.8	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
127	25765070	TIMP1	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
128	25765070	IL1R2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
129	25765070	DPP4	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
130	25765070	SLC13A3	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
131	25765070	ITGA1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
132	25765070	ASCC3	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
133	25765070	PIK3CG	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
134	25765070	E2F2	9.1	0.529	0.276544327964814	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
135	25765070	ADAM12	9.1	0.529	0.276544327964814	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
136	25765070	ESR1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
137	25765070	EGFL7	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
138	25765070	YTHDF2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
139	25765070	ACTA2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
140	25765070	ESRRA	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
141	25765070	MCAM	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
142	25765070	NUDT21	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
143	25765070	LILRB1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
144	25765070	CTNNB1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
145	25765070	KDR	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
146	25765070	CXCL1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
147	25765070	TLR3	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
148	25765070	NDRG1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
149	25765070	RECQL4	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
150	25765070	NACC1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
151	25765070	PDCD1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
152	25765070	ANGPT2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
153	25765070	ARID5A	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
154	25765070	COL6A5	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
155	25765070	CD109	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
156	25765070	WNT16	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
157	25765070	ABL2	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
158	25765070	ENTPD1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
159	25765070	WNT1	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
160	25765070	CDCA4	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
161	25765070	ATR	4.5	1	0	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
162	25765070	IGF1R	-8.3	0.353	0.452225294612177	dpGAP_phs000980.v1.p1.	Non-small cell lung cancer	Pembrolizumab	14	17	TISIDB	Mut_1
163	26359337	IGF1R	-11.9	0.118	0.928117992693875	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
164	26359337	MAPK1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
165	26359337	NOTCH2	4.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
166	26359337	AKT3	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
167	26359337	ANK3	-19.8	0.149	0.826813731587726	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
168	26359337	ASCC3	0.899999999999999	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
169	26359337	BACH2	-16.5	0.013	1.88605664769316	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
170	26359337	COL11A1	4.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
171	26359337	DIAPH3	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
172	26359337	EHMT2	-9.5	0.122	0.913640169325252	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
173	26359337	FNDC3B	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
174	26359337	HEY1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
175	26359337	ICAM1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
176	26359337	MMP14	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
177	26359337	POLQ	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
178	26359337	PPARGC1A	11.4	0.36	0.443697499232713	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
179	26359337	TYMS	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
180	26359337	APC	-8.5	0.38	0.42021640338319	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
181	26359337	ATR	-8.5	0.38	0.42021640338319	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
182	26359337	C1QC	-8.4	0.184	0.735182176990464	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
183	26359337	COL6A6	-2.7	0.663	0.178486471595227	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
184	26359337	DPP4	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
185	26359337	HHLA2	-9.6	0.204	0.690369832574101	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
186	26359337	JAK2	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
187	26359337	MAP4K1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
188	26359337	KMT2C	-4	0.707	0.150580586203101	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
189	26359337	NOTCH1	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
190	26359337	STAB1	4.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
191	26359337	STC2	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
192	26359337	TNC	-18	0.0654	1.18442225167573	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
193	26359337	CCDC69	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
194	26359337	FOLH1	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
195	26359337	FOXO1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
196	26359337	HLA-DRB5	-11.9	0.118	0.928117992693875	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
197	26359337	PEF1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
198	26359337	RB1	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
199	26359337	SLIT2	3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
200	26359337	DGKZ	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
201	26359337	PIK3R1	-11.9	0.118	0.928117992693875	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
202	26359337	SMG1	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
203	26359337	UBA3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
204	26359337	WNT5A	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
205	26359337	YTHDF1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
206	26359337	ARHGAP10	-6.1	0.316	0.500312917381596	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
207	26359337	BMP2	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
208	26359337	HDAC9	-14.4	0.102	0.991399828238082	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
209	26359337	HSPA4	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
210	26359337	NFX1	6.8	0.586	0.232102383981909	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
211	26359337	NOS2	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
212	26359337	NR4A1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
213	26359337	PRKACA	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
214	26359337	PTPRT	5.2	0.733	0.134896025358872	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
215	26359337	WWTR1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
216	26359337	CD86	8	0.595	0.22548303427145	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
217	26359337	CHAF1A	-6.1	0.316	0.500312917381596	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
218	26359337	DDR1	8	0.595	0.22548303427145	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
219	26359337	HLA-DQA1	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
220	26359337	KEAP1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
221	26359337	LAG3	6.8	0.586	0.232102383981909	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
222	26359337	LRP1B	0.100000000000001	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
223	26359337	MTOR	-10.8	0.159	0.798602875679548	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
224	26359337	MUC4	-2.7	0.663	0.178486471595227	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
225	26359337	NOTCH4	-19.2	0.0487	1.31247103878537	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
226	26359337	RGS1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
227	26359337	SHC3	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
228	26359337	TNFSF10	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
229	26359337	TP53	11.4	0.36	0.443697499232713	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
230	26359337	TRIM22	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
231	26359337	VCAN	1.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
232	26359337	YAP1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
233	26359337	PIK3R3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
234	26359337	SQSTM1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
235	26359337	CCR4	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
236	26359337	COL2A1	-2.7	0.663	0.178486471595227	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
237	26359337	COL6A2	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
238	26359337	EDN1	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
239	26359337	HLA-DQB1	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
240	26359337	IFNB1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
241	26359337	IL1B	-13.1	0.0822	1.08512818245995	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
242	26359337	LILRB1	-3.8	0.636	0.196542884351586	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
243	26359337	SELE	-7.3	0.249	0.603800652904264	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
244	26359337	SERPINE1	-9.5	0.122	0.913640169325252	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
245	26359337	UBR5	-19	0.0225	1.64781748188864	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
246	26359337	PRKG1	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
247	26359337	GNAS	-19.2	0.0487	1.31247103878537	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
248	26359337	HGF	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
249	26359337	IL33	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
250	26359337	MRAP	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
251	26359337	XBP1	-11.8	0.0249	1.60380065290426	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
252	26359337	HLA-DQB2	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
253	26359337	AHR	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
254	26359337	ITGA4	2.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
255	26359337	SMAD4	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
256	26359337	ABCB1	2.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
257	26359337	ABL2	6.8	0.586	0.232102383981909	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
258	26359337	ALDH2	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
259	26359337	ARG2	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
260	26359337	ARID1A	2.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
261	26359337	ATF3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
262	26359337	ATRX	3.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
263	26359337	CASP8	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
264	26359337	CCL25	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
265	26359337	CD276	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
266	26359337	COL6A3	4.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
267	26359337	COL6A5	-10.8	0.159	0.798602875679548	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
268	26359337	CXCL10	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
269	26359337	EDNRA	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
270	26359337	EGF	2.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
271	26359337	EZH2	-7.3	0.249	0.603800652904264	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
272	26359337	FGF21	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
273	26359337	FN1	-6.1	0.316	0.500312917381596	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
274	26359337	HAVCR2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
275	26359337	HLA-DOA	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
276	26359337	IGF2R	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
277	26359337	ITGAE	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
278	26359337	KLRK1	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
279	26359337	KRT17	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
280	26359337	MKI67	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
281	26359337	NOS3	-8.4	0.184	0.735182176990464	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
282	26359337	NT5E	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
283	26359337	PDCD1	0.899999999999999	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
284	26359337	PDHX	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
285	26359337	PFKFB3	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
286	26359337	PPARG	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
287	26359337	PRKD3	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
288	26359337	PTK2	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
289	26359337	PVR	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
290	26359337	ROS1	5.2	0.733	0.134896025358872	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
291	26359337	SMAD5	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
292	26359337	SNHG1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
293	26359337	TAP2	0.899999999999999	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
294	26359337	TERT	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
295	26359337	TLR2	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
296	26359337	VEGFA	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
297	26359337	WNT3A	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
298	26359337	ADAM12	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
299	26359337	AKT1	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
300	26359337	ALOX5	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
301	26359337	ARID5A	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
302	26359337	CD8B	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
303	26359337	CSF2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
304	26359337	CTNNB1	-11.9	0.118	0.928117992693875	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
305	26359337	CXCL13	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
306	26359337	CXCL14	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
307	26359337	CXCL5	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
308	26359337	CXCR1	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
309	26359337	CXCR2	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
310	26359337	DCLK1	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
311	26359337	DLL3	6.8	0.586	0.232102383981909	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
312	26359337	EGFR	5.5	0.688	0.162411561764489	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
313	26359337	EIF4A3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
314	26359337	EOMES	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
315	26359337	EPHA2	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
316	26359337	ERBB2	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
317	26359337	FAP	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
318	26359337	FBXW7	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
319	26359337	FGL1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
320	26359337	FLT3LG	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
321	26359337	G3BP1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
322	26359337	GPC3	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
323	26359337	GPM6A	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
324	26359337	HLA-C	-6.1	0.316	0.500312917381596	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
325	26359337	HLA-DMB	-8.4	0.184	0.735182176990464	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
326	26359337	HLA-DPA1	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
327	26359337	HLA-DRA	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
328	26359337	IDO1	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
329	26359337	IFNG	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
330	26359337	IL10	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
331	26359337	IL12A	-9.5	0.122	0.913640169325252	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
332	26359337	IL12B	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
333	26359337	IL1R2	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
334	26359337	IL2RA	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
335	26359337	IL7	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
336	26359337	IRF1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
337	26359337	ITGA1	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
338	26359337	ITGB3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
339	26359337	KDR	-22.6	0.0156	1.80687540164554	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
340	26359337	CEMIP	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
341	26359337	KLRB1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
342	26359337	KRAS	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
343	26359337	LILRB2	-20.1	0.0126	1.89962945488244	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
344	26359337	MYCN	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
345	26359337	NES	8	0.595	0.22548303427145	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
346	26359337	NFKB1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
347	26359337	NOD1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
348	26359337	OLR1	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
349	26359337	PBX1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
350	26359337	PCSK9	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
351	26359337	PDGFRA	-2.7	0.663	0.178486471595227	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
352	26359337	PFKP	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
353	26359337	PIK3CG	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
354	26359337	PIKFYVE	3.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
355	26359337	PPARA	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
356	26359337	PPP3CB	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
357	26359337	PRDM1	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
358	26359337	PTPN6	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
359	26359337	RAF1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
360	26359337	RHOA	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
361	26359337	SDC1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
362	26359337	SELP	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
363	26359337	SLC7A5	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
364	26359337	SOX2	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
365	26359337	TAPBP	-7.3	0.249	0.603800652904264	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
366	26359337	TDO2	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
367	26359337	TLR3	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
368	26359337	TOX	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
369	26359337	TPPP3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
370	26359337	TSC22D1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
371	26359337	VCAM1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
372	26359337	WNT2	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
373	26359337	WNT3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
374	26359337	WNT9B	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
375	26359337	ZEB1	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
376	26359337	AGRN	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
377	26359337	FASLG	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
378	26359337	ITGB4	-6.1	0.316	0.500312917381596	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
379	26359337	PIK3CA	-11.8	0.0249	1.60380065290426	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
380	26359337	RECQL4	-0.2	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
381	26359337	STAT3	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
382	26359337	ARG1	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
383	26359337	CCL21	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
384	26359337	HDAC2	-10.7	0.0675	1.17069622716898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
385	26359337	HLA-A	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
386	26359337	HLA-DMA	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
387	26359337	PTGS2	-8.4	0.184	0.735182176990464	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
388	26359337	TREX1	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
389	26359337	USP7	-7.3	0.249	0.603800652904264	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
390	26359337	WNT8A	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
391	26359337	CD4	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
392	26359337	NOTCH3	6.8	0.586	0.232102383981909	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
393	26359337	PDGFD	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
394	26359337	PIK3C3	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
395	26359337	STAT5B	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
396	26359337	FTO	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
397	26359337	OIP5	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
398	26359337	TIGIT	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
399	26359337	CD93	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
400	26359337	PF4	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
401	26359337	WNT16	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
402	26359337	CD44	-10.7	0.0675	1.17069622716898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
403	26359337	MAPK8	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
404	26359337	NFATC1	-9.5	0.122	0.913640169325252	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
405	26359337	PECAM1	-10.7	0.0675	1.17069622716898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
406	26359337	CX3CL1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
407	26359337	TIMP1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
408	26359337	TPP2	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
409	26359337	B2M	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
410	26359337	AR	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
411	26359337	CPT1A	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
412	26359337	KLRC1	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
413	26359337	IFNL3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
414	26359337	COL6A1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
415	26359337	PRF1	5.7	0.589	0.229884705212898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
416	26359337	CASP3	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
417	26359337	CXCR6	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
418	26359337	FGF2	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
419	26359337	HAS2	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
420	26359337	IFNGR1	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
421	26359337	IRAK4	-16.5	0.013	1.88605664769316	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
422	26359337	ITGB1	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
423	26359337	LDHA	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
424	26359337	LGALS9	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
425	26359337	LOX	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
426	26359337	MDM2	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
427	26359337	PDK1	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
428	26359337	PIK3C2B	-9.5	0.122	0.913640169325252	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
429	26359337	PSAT1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
430	26359337	PTEN	-5	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
431	26359337	ROCK1	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
432	26359337	ROCK2	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
433	26359337	SGCB	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
434	26359337	SH3PXD2A	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
435	26359337	SMARCA2	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
436	26359337	ACLY	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
437	26359337	ACOX1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
438	26359337	ADORA2A	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
439	26359337	ALKBH5	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
440	26359337	ALYREF	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
441	26359337	CALM2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
442	26359337	CCL22	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
443	26359337	CD109	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
444	26359337	DNMT3A	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
445	26359337	EBNA1BP2	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
446	26359337	ELK3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
447	26359337	FAS	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
448	26359337	FASN	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
449	26359337	HLA-DPB1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
450	26359337	HNF1A	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
451	26359337	IRAK1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
452	26359337	JAG1	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
453	26359337	KDM1A	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
454	26359337	LGALS8	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
455	26359337	MAP3K11	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
456	26359337	MMP2	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
457	26359337	MYBL2	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
458	26359337	NFE2L2	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
459	26359337	PIK3CB	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
460	26359337	PIK3R2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
461	26359337	PPT1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
462	26359337	RIPK3	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
463	26359337	SBSN	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
464	26359337	SELL	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
465	26359337	SLC6A8	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
466	26359337	SREBF2	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
467	26359337	STAT5A	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
468	26359337	STEAP4	8	0.595	0.22548303427145	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
469	26359337	SUGT1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
470	26359337	TAP1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
471	26359337	TBX21	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
472	26359337	WNT10B	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
473	26359337	BAX	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
474	26359337	CD38	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
475	26359337	CD47	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
476	26359337	GZMB	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
477	26359337	PDPN	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
478	26359337	BCL2	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
479	26359337	CAMP	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
480	26359337	CISH	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
481	26359337	POU2F1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
482	26359337	PPP3CA	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
483	26359337	ACKR3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
484	26359337	FGR	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
485	26359337	F2RL1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
486	26359337	BRD4	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
487	26359337	CD274	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
488	26359337	CSF1R	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
489	26359337	ENG	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
490	26359337	HYAL1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
491	26359337	IDH1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
492	26359337	PIGL	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
493	26359337	PRKCE	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
494	26359337	CCR2	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
495	26359337	CD244	-2.5	0.512	0.290730039024169	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
496	26359337	IL2	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
497	26359337	PPBP	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
498	26359337	ACTA1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
499	26359337	ACTA2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
500	26359337	AKT2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
501	26359337	ANGPT2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
502	26359337	BATF3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
503	26359337	C1QA	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
504	26359337	CARD9	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
505	26359337	CCL20	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
506	26359337	CX3CR1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
507	26359337	ST14	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
508	26359337	WNT6	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
509	26359337	PIK3CD	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
510	26359337	PABPC1L	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
511	26359337	CTLA4	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
512	26359337	TGFB2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
513	26359337	HIF1A	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
514	26359337	MMP9	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
515	26359337	ATG7	0	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
516	26359337	BCL2L1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
517	26359337	C1QB	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
518	26359337	CCL19	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
519	26359337	CSF1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
520	26359337	CXCL12	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
521	26359337	IRF8	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
522	26359337	MRGPRX3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
523	26359337	SLC13A3	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
524	26359337	TNF	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
525	26359337	CCL3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
526	26359337	GPER1	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
527	26359337	NFATC2	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
528	26359337	NACC1	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
529	26359337	RCAN1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
530	26359337	SLC2A1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
531	26359337	IRF4	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
532	26359337	HLA-DQA2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
533	26359337	BATF	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
534	26359337	CXCL1	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
535	26359337	FGF4	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
536	26359337	FGFR1	-17.6	0.00363	2.44009337496389	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
537	26359337	IGF1	-10.7	0.0675	1.17069622716898	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
538	26359337	LTB4R2	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
539	26359337	NBR1	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
540	26359337	POU5F1	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
541	26359337	TFEB	-4.8	0.299	0.52432881167557	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
542	26359337	TRIB3	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
543	26359337	CRTAM	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
544	26359337	CXCL8	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
545	26359337	SPP1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
546	26359337	CD80	4.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
547	26359337	MYC	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
548	26359337	CALM1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
549	26359337	ENTPD1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
550	26359337	STK11	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
551	26359337	UCP1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
552	26359337	YTHDF2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
553	26359337	FOXP3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
554	26359337	NDRG1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
555	26359337	PARP1	3.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
556	26359337	CD58	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
557	26359337	CDH1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
558	26359337	GPX2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
559	26359337	NR0B1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
560	26359337	NUDT21	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
561	26359337	SREBF1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
562	26359337	WNT2B	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
563	26359337	GABPA	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
564	26359337	CD40	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
565	26359337	HK2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
566	26359337	MCAM	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
567	26359337	TREM2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
568	26359337	E2F2	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
569	26359337	FFAR2	-3.6	0.415	0.381951903287907	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
570	26359337	MAT1A	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
571	26359337	CCL17	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
572	26359337	NOG	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
573	26359337	ITGA2	-5.9	0.162	0.790484985457369	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
574	26359337	CMC1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
575	26359337	FOLR2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
576	26359337	CALM3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
577	26359337	BGN	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
578	26359337	SHOX2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Ipilimumab	27	73	TISIDB	Mut_2
579	26997480	ABCB1	-17.9	0.197	0.705533773838407	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
580	26997480	ANK3	-15.9	0.515	0.288192770958809	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
581	26997480	ARHGAP10	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
582	26997480	ATRX	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
583	26997480	CD47	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
584	26997480	COL11A1	-6.2	0.709	0.149353764816933	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
585	26997480	COL2A1	19.9	0.207	0.684029654543082	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
586	26997480	COL6A5	-21.5	0.148	0.829738284605043	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
587	26997480	COL6A6	-16.8	0.257	0.590066876668705	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
588	26997480	CXCR4	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
589	26997480	FN1	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
590	26997480	FOLH1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
591	26997480	GPM6A	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
592	26997480	HDAC9	-6.2	0.709	0.149353764816933	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
593	26997480	HHLA2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
594	26997480	HMGB1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
595	26997480	ITGA2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
596	26997480	ITGB4	8.1	0.64	0.193820026016113	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
597	26997480	KDR	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
598	26997480	KLRC1	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
599	26997480	KMT2C	-13.1	0.355	0.449771646944906	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
600	26997480	LILRB1	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
601	26997480	LRP1B	-5.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
602	26997480	MAT1A	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
603	26997480	MCAM	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
604	26997480	NES	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
605	26997480	NOS3	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
606	26997480	PCSK9	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
607	26997480	PGF	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
608	26997480	PIK3R1	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
609	26997480	PPARG	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
610	26997480	PTPRT	-25.3	0.161	0.79317412396815	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
611	26997480	SBSN	12.8	0.307	0.512861624522813	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
612	26997480	SLIT2	-9.8	0.721	0.142064735280571	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
613	26997480	TFEB	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
614	26997480	TP53	9.2	0.678	0.168770306132937	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
615	26997480	WNT2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
616	26997480	AGRN	12.8	0.307	0.512861624522813	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
617	26997480	ANGPT2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
618	26997480	CD109	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
619	26997480	CD40	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
620	26997480	CD86	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
621	26997480	COL6A3	-11	0.476	0.322393047279507	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
622	26997480	DCLK1	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
623	26997480	EGF	-13.1	0.355	0.449771646944906	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
624	26997480	EPHA2	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
625	26997480	EZH2	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
626	26997480	FGR	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
627	26997480	GNAS	-8.4	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
628	26997480	HLA-DQA2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
629	26997480	IL7	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
630	26997480	ITGA4	15.1	0.426	0.370590400897281	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
631	26997480	JAG1	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
632	26997480	MTOR	-23.8	0.0529	1.27654432796481	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
633	26997480	PIK3CA	-2.5	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
634	26997480	PIK3CG	-13.1	0.355	0.449771646944906	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
635	26997480	POLQ	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
636	26997480	POU2F1	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
637	26997480	PPARA	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
638	26997480	PPARGC1A	12.8	0.307	0.512861624522813	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
639	26997480	PTPN6	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
640	26997480	ROS1	0.799999999999997	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
641	26997480	SELE	-19	0.113	0.94692155651658	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
642	26997480	SELP	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
643	26997480	TNC	-13.1	0.355	0.449771646944906	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
644	26997480	VCAN	-8.4	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
645	26997480	WNT5B	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
646	26997480	ACKR3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
647	26997480	AHR	-19	0.113	0.94692155651658	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
648	26997480	AKT3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
649	26997480	BGN	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
650	26997480	CD38	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
651	26997480	CXCL11	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
652	26997480	DPP4	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
653	26997480	IL1A	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
654	26997480	LILRB2	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
655	26997480	MKI67	3.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
656	26997480	PRF1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
657	26997480	PTEN	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
658	26997480	SLC7A5	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
659	26997480	STAB1	-22.7	0.104	0.98296666070122	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
660	26997480	TLR2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
661	26997480	TRIM22	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
662	26997480	YTHDF2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
663	26997480	ACTA1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
664	26997480	ALKBH5	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
665	26997480	ALOX5	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
666	26997480	APC	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
667	26997480	ASCC3	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
668	26997480	ATG7	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
669	26997480	ATR	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
670	26997480	BMP2	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
671	26997480	C1QB	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
672	26997480	CARD9	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
673	26997480	COL6A1	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
674	26997480	CXCL12	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
675	26997480	CXCL13	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
676	26997480	CXCR1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
677	26997480	FTO	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
678	26997480	G3BP1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
679	26997480	HGF	-13.1	0.355	0.449771646944906	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
680	26997480	IDO1	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
681	26997480	IGF1R	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
682	26997480	IL1B	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
683	26997480	IL2RA	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
684	26997480	IRF4	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
685	26997480	ITGA1	8.1	0.64	0.193820026016113	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
686	26997480	ITGB1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
687	26997480	JAK2	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
688	26997480	CEMIP	-8.4	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
689	26997480	LDHA	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
690	26997480	MRGPRX3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
691	26997480	MYBL2	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
692	26997480	NFX1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
693	26997480	NOTCH3	-1.4	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
694	26997480	PABPC1L	-8.4	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
695	26997480	PDGFRA	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
696	26997480	PDPN	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
697	26997480	PF4	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
698	26997480	PIK3C2B	3.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
699	26997480	PIK3C3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
700	26997480	PIK3CB	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
701	26997480	PRKG1	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
702	26997480	SELL	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
703	26997480	SHOX2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
704	26997480	SPP1	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
705	26997480	TERT	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
706	26997480	TIGIT	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
707	26997480	TLR3	-8.4	0.613	0.212539525481585	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
708	26997480	TPP2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
709	26997480	TSC22D1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
710	26997480	WNT10A	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
711	26997480	ZEB1	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
712	26997480	FABP4	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
713	26997480	SMG1	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
714	26997480	UBA3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
715	26997480	USP7	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
716	26997480	FGFR1	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
717	26997480	IL12B	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
718	26997480	NOTCH1	-3.6	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
719	26997480	VCAM1	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
720	26997480	CTNNB1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
721	26997480	EDNRA	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
722	26997480	ESR1	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
723	26997480	FOXP3	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
724	26997480	IL1R2	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
725	26997480	MMP2	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
726	26997480	PIKFYVE	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
727	26997480	RB1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
728	26997480	TIMP1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
729	26997480	TOX	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
730	26997480	CALM2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
731	26997480	COL6A2	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
732	26997480	CSF1R	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
733	26997480	ENG	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
734	26997480	ERBB2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
735	26997480	FASN	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
736	26997480	IGF2R	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
737	26997480	IRF8	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
738	26997480	MYOZ3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
739	26997480	PFKFB3	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
740	26997480	SREBF1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
741	26997480	CD4	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
742	26997480	COTL1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
743	26997480	MUC4	-13.1	0.355	0.449771646944906	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
744	26997480	NOS2	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
745	26997480	NOD1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
746	26997480	TBX21	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
747	26997480	SOX2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
748	26997480	DNMT3A	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
749	26997480	E2F2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
750	26997480	STEAP4	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
751	26997480	BACH2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
752	26997480	CCDC69	11.8	0.193	0.714442690992226	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
753	26997480	ENTPD1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
754	26997480	FNDC3B	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
755	26997480	HLA-DRB1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
756	26997480	ITGAE	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
757	26997480	LGALS9	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
758	26997480	MAP4K1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
759	26997480	NR0B1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
760	26997480	NR4A1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
761	26997480	OLR1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
762	26997480	PDGFD	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
763	26997480	PRKCE	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
764	26997480	PTGES2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
765	26997480	SLC13A3	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
766	26997480	TRIB3	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
767	26997480	WNT8A	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
768	26997480	ACOX1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
769	26997480	ARID1A	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
770	26997480	BHLHA15	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
771	26997480	IL13	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
772	26997480	CX3CL1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
773	26997480	EGFR	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
774	26997480	HNF1A	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
775	26997480	PBX1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
776	26997480	UBR5	2.3	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
777	26997480	WWTR1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
778	26997480	ADAM12	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
779	26997480	ARG1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
780	26997480	CD93	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
781	26997480	CSF1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
782	26997480	CXCR2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
783	26997480	IFNA1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
784	26997480	KLRK1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
785	26997480	NOTCH2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
786	26997480	ST14	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
787	26997480	STK11	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
788	26997480	TDO2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
789	26997480	SMAD4	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
790	26997480	WNT7A	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
791	26997480	C1QA	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
792	26997480	CD44	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
793	26997480	CX3CR1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
794	26997480	ELK3	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
795	26997480	IFNL3	7	0.577	0.238824186844269	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
796	26997480	NACC1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
797	26997480	WNT9A	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
798	26997480	FASLG	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
799	26997480	CD244	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
800	26997480	TUBA1B	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
801	26997480	EOMES	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
802	26997480	TGFB2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
803	26997480	CD80	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
804	26997480	CXCL5	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
805	26997480	HBEGF	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
806	26997480	IL2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
807	26997480	STAT5B	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
808	26997480	ADORA2A	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
809	26997480	PRDM1	1.1	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
810	26997480	SMARCA2	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
811	26997480	IRAK1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
812	26997480	CHAF1A	-9.5	0.492	0.30803489723264	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
813	26997480	KDM1A	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
814	26997480	RAF1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
815	26997480	SREBF2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
816	26997480	PFKP	-14.3	0.238	0.623423042943488	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
817	26997480	CPT1A	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
818	26997480	NFATC1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
819	26997480	IL33	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
820	26997480	WNT10B	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
821	26997480	ABL2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
822	26997480	BATF	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
823	26997480	BMI1	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
824	26997480	BRD4	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
825	26997480	DIAPH3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
826	26997480	GPC3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
827	26997480	IFNG	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
828	26997480	JUND	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
829	26997480	ROCK2	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
830	26997480	STAT3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
831	26997480	WNT16	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
832	26997480	WNT3A	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
833	26997480	ITGB3	-4.8	1	0	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
834	26997480	HYAL1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
835	26997480	IFNGR1	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
836	26997480	SHC3	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
837	26997480	B2M	5.9	0.447	0.349692476868064	dbGap_phs000452.v2.p1	Melanoma	Pembrolizumab or Nivolumab	21	17	TISIDB	Mut_3
838	28552987	AGRN	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
839	28552987	PPT1	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
840	28552987	PCSK9	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
841	28552987	SELP	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
842	28552987	ANK3	-14.3	0.574	0.241088107602027	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
843	28552987	WNT5B	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
844	28552987	TP53	-14.2	0.659	0.18111458540599	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
845	28552987	FASN	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
846	28552987	DLL3	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
847	28552987	AKT2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
848	28552987	LILRB1	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
849	28552987	IL1R2	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
850	28552987	NFE2L2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
851	28552987	PDCD1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
852	28552987	BMP2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
853	28552987	NFATC2	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
854	28552987	MAPK1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
855	28552987	SREBF2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
856	28552987	PIK3CB	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
857	28552987	ATR	-21.5	0.247	0.607303046740334	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
858	28552987	WWTR1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
859	28552987	CD38	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
860	28552987	KDR	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
861	28552987	GPM6A	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
862	28552987	IRF1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
863	28552987	PDLIM7	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
864	28552987	NOS3	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
865	28552987	CTNNBIP1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
866	28552987	SLC2A1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
867	28552987	RGS1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
868	28552987	PRF1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
869	28552987	MAP3K11	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
870	28552987	CPT1A	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
871	28552987	PDGFD	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
872	28552987	FOXO1	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
873	28552987	MMP2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
874	28552987	ACLY	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
875	28552987	STAT5B	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
876	28552987	STAT3	-21.5	0.247	0.607303046740334	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
877	28552987	SBSN	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
878	28552987	TGFB1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
879	28552987	FAP	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
880	28552987	WNT6	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
881	28552987	WNT10A	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
882	28552987	PTPRT	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
883	28552987	COL6A1	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
884	28552987	COL6A2	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
885	28552987	PPARG	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
886	28552987	WNT5A	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
887	28552987	TERT	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
888	28552987	SQSTM1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
889	28552987	DDR1	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
890	28552987	PIK3CG	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
891	28552987	KMT2C	-57.1	0.0237	1.6252516539899	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
892	28552987	ENG	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
893	28552987	AR	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
894	28552987	ARID1A	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
895	28552987	NOTCH3	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
896	28552987	SLIT2	21.4	0.521	0.283162276700476	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
897	28552987	FOLH1	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
898	28552987	FGF4	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
899	28552987	ESR1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
900	28552987	PTK2	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
901	28552987	NOTCH2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
902	28552987	ABL2	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
903	28552987	TGFB2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
904	28552987	ZEB1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
905	28552987	COL2A1	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
906	28552987	BATF	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
907	28552987	CDH1	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
908	28552987	SREBF1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
909	28552987	WNT3	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
910	28552987	ROCK2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
911	28552987	LRP1B	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
912	28552987	STAT1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
913	28552987	PABPC1L	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
914	28552987	CD40	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
915	28552987	SLC13A3	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
916	28552987	WNT7A	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
917	28552987	FNDC3B	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
918	28552987	PIK3CA	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
919	28552987	FBXW7	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
920	28552987	EDN1	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
921	28552987	EHMT2	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
922	28552987	CD109	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
923	28552987	IGF2R	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
924	28552987	EGFR	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
925	28552987	WNT2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
926	28552987	NFX1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
927	28552987	MAOA	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
928	28552987	SLC6A8	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
929	28552987	E2F2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
930	28552987	MMP14	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
931	28552987	ICAM1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
932	28552987	FN1	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
933	28552987	ONECUT3	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
934	28552987	CD8A	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
935	28552987	PFKFB3	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
936	28552987	PIK3CD	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
937	28552987	WNT4	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
938	28552987	FGR	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
939	28552987	CD244	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
940	28552987	BATF3	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
941	28552987	PARP1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
942	28552987	ESRRA	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
943	28552987	CRTAM	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
944	28552987	WNT10B	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
945	28552987	TSC22D1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
946	28552987	PRMT5	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
947	28552987	ARG2	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
948	28552987	PGF	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
949	28552987	SPINT1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
950	28552987	OIP5	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
951	28552987	SMG1	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
952	28552987	FTO	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
953	28552987	TBX21	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
954	28552987	ITGB4	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
955	28552987	ACOX1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
956	28552987	JUND	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
957	28552987	DNMT3A	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
958	28552987	ITGA4	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
959	28552987	COL6A3	21.4	0.521	0.283162276700476	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
960	28552987	GABPA	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
961	28552987	ATG7	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
962	28552987	CTNNB1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
963	28552987	STAB1	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
964	28552987	MUC4	21.4	0.521	0.283162276700476	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
965	28552987	IGFBP7	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
966	28552987	NFKB1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
967	28552987	EGF	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
968	28552987	VCAN	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
969	28552987	HLA-DQB2	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
970	28552987	NT5E	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
971	28552987	ASCC3	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
972	28552987	UBR5	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
973	28552987	ATRX	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
974	28552987	XCL1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
975	28552987	WNT9A	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
976	28552987	WNT11	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
977	28552987	ST14	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
978	28552987	NR4A1	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
979	28552987	DCLK1	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
980	28552987	NFATC1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
981	28552987	BRD4	21.4	0.521	0.283162276700476	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
982	28552987	IFNL3	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
983	28552987	LILRB2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
984	28552987	IL1A	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
985	28552987	PRDM1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
986	28552987	FGFR1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
987	28552987	NOTCH1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
988	28552987	PBX1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
989	28552987	PFKP	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
990	28552987	ERBB2	21.4	0.521	0.283162276700476	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
991	28552987	NBR1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
992	28552987	PIKFYVE	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
993	28552987	COL6A5	21.4	0.521	0.283162276700476	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
994	28552987	FGF2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
995	28552987	MAPK14	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
996	28552987	C1QA	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
997	28552987	DGKZ	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
998	28552987	RB1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
999	28552987	STAT5A	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1000	28552987	ROCK1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1001	28552987	COL6A6	-7.2	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1002	28552987	NOTCH4	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1003	28552987	FGL1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1004	28552987	METTL3	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1005	28552987	PRKCE	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1006	28552987	SGCB	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1007	28552987	VEGFA	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1008	28552987	COL11A1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1009	28552987	KLRC1	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1010	28552987	ALKBH5	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1011	28552987	CASP8	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1012	28552987	EDNRA	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1013	28552987	ARHGAP10	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1014	28552987	HLA-C	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1015	28552987	IFNGR1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1016	28552987	FOXP3	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1017	28552987	GPC3	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1018	28552987	BSG	14.3	0.533	0.273272790973428	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1019	28552987	KEAP1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1020	28552987	CD8B	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1021	28552987	TOX	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1022	28552987	SUGT1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1023	28552987	VCAM1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1024	28552987	ADAM12	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1025	28552987	CD4	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1026	28552987	PPARGC1A	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1027	28552987	IL2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1028	28552987	C1QC	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1029	28552987	HNF1A	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1030	28552987	CHAF1A	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1031	28552987	TRIB3	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1032	28552987	RAF1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1033	28552987	POLQ	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1034	28552987	PIK3R1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1035	28552987	IGF1R	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1036	28552987	APC	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1037	28552987	ADA	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1038	28552987	ITGA1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1039	28552987	PSMB9	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1040	28552987	TAP1	-28.6	0.1	1	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1041	28552987	ARG1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1042	28552987	MTOR	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1043	28552987	CALM1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1044	28552987	CEMIP	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1045	28552987	ITGB3	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1046	28552987	CALM2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1047	28552987	HDAC2	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1048	28552987	ROS1	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1049	28552987	IL12A	-14.3	0.333	0.47755576649368	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1050	28552987	KDM1A	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1051	28552987	CXCR5	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1052	28552987	ITGAE	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1053	28552987	ICAM2	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1054	28552987	ID4	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1055	28552987	ANGPT2	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1056	28552987	BACH2	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1057	28552987	ENTPD1	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1058	28552987	PDGFRA	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1059	28552987	PIK3C2B	7.1	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1060	28552987	SELL	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1061	28552987	SELE	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1062	28552987	PRKG1	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1063	28552987	GNAS	0	1	0	doi.org/10.5281/zenodo.546110.	Urothelial cancer	Atezolizumab	9	16	TISIDB	Mut_4
1064	29033130	MUC4	-12.7	0.381	0.419075024324381	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1065	29033130	VCAN	-12	0.338	0.471083299722345	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1066	29033130	HLA-DRB1	-16	0.0761	1.11861534322943	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1067	29033130	NR0B1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1068	29033130	COL11A1	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1069	29033130	MMP2	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1070	29033130	PRMT1	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1071	29033130	JAG1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1072	29033130	COL6A2	1.3	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1073	29033130	HHLA2	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1074	29033130	COL6A5	-14.7	0.221	0.655607726314889	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1075	29033130	PDLIM7	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1076	29033130	KRAS	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1077	29033130	ARID1A	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1078	29033130	ANK3	-20	0.17	0.769551078621726	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1079	29033130	COL2A1	-8	0.42	0.3767507096021	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1080	29033130	TSC22D1	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1081	29033130	CDCA4	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1082	29033130	SMG1	-0.7	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1083	29033130	PRKCE	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1084	29033130	COL6A3	6.7	0.717	0.1444808443322	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1085	29033130	GNAS	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1086	29033130	EGF	-5.3	0.615	0.211124884224583	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1087	29033130	CSF1R	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1088	29033130	CCDC69	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1089	29033130	HLA-DPB1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1090	29033130	AGRN	-8	0.42	0.3767507096021	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1091	29033130	NOTCH3	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1092	29033130	GPC3	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1093	29033130	DPP4	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1094	29033130	PTPRT	-25.3	0.025	1.60205999132796	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1095	29033130	COL6A6	-12	0.338	0.471083299722345	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1096	29033130	E2F2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1097	29033130	PRKG1	-20	0.0104	1.98296666070122	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1098	29033130	TBX21	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1099	29033130	LRP1B	-18.7	0.214	0.669586226650809	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1100	29033130	RHOA	-20	0.0104	1.98296666070122	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1101	29033130	PIK3CA	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1102	29033130	PTGS2	0	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1103	29033130	HIF1A	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1104	29033130	AKT1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1105	29033130	TP53	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1106	29033130	CCL4	0	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1107	29033130	SREBF2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1108	29033130	CD86	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1109	29033130	SPP1	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1110	29033130	ITGA1	-29.3	0.00565	2.24795155218056	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1111	29033130	HLA-DOB	0	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1112	29033130	MAPK14	0	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1113	29033130	ROS1	-32	0.00719	2.14327110961712	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1114	29033130	HDAC9	-5.3	0.615	0.211124884224583	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1115	29033130	TOX	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1116	29033130	NFIL3	0	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1117	29033130	MTOR	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1118	29033130	DIAPH3	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1119	29033130	STAB1	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1120	29033130	HLA-DQB2	-0.7	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1121	29033130	APC	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1122	29033130	CPT1A	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1123	29033130	CSF2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1124	29033130	HLA-A	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1125	29033130	HLA-DQB1	10	0.582	0.235077015350112	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1126	29033130	NOTCH2	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1127	29033130	MDM2	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1128	29033130	LILRB2	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1129	29033130	SLIT2	-27.3	0.0129	1.88941028970075	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1130	29033130	PDGFRA	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1131	29033130	HAVCR2	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1132	29033130	PIK3CG	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1133	29033130	NOS3	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1134	29033130	POLQ	-12	0.338	0.471083299722345	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1135	29033130	FBXW7	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1136	29033130	IL12B	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1137	29033130	DDR1	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1138	29033130	VCAM1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1139	29033130	SELP	-5.3	0.615	0.211124884224583	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1140	29033130	ALOX5	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1141	29033130	MAP4K1	1.3	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1142	29033130	PRKD3	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1143	29033130	PPARG	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1144	29033130	HLA-DRB5	3.3	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1145	29033130	ADAM12	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1146	29033130	HK2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1147	29033130	GABPA	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1148	29033130	HYAL2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1149	29033130	PBX1	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1150	29033130	LGALS3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1151	29033130	CHAF1A	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1152	29033130	TLR3	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1153	29033130	IL6	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1154	29033130	IDO1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1155	29033130	ITGAE	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1156	29033130	CX3CR1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1157	29033130	NOTCH4	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1158	29033130	PDCD1LG2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1159	29033130	TNC	-20.7	0.0441	1.35556141053216	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1160	29033130	ATRX	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1161	29033130	PIK3C2B	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1162	29033130	PFKP	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1163	29033130	IGF1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1164	29033130	CCR2	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1165	29033130	FFAR2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1166	29033130	HAS2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1167	29033130	PDPN	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1168	29033130	EPHA2	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1169	29033130	MAP3K11	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1170	29033130	IDH2	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1171	29033130	IL1B	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1172	29033130	TNFSF10	-7.3	0.325	0.488116639021126	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1173	29033130	KMT2C	1.3	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1174	29033130	ANGPT2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1175	29033130	MCAM	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1176	29033130	ALDH2	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1177	29033130	IRF8	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1178	29033130	CASP8	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1179	29033130	EDNRA	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1180	29033130	HLA-DQA2	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1181	29033130	NT5E	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1182	29033130	ASCC3	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1183	29033130	EGFR	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1184	29033130	SHC3	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1185	29033130	MAOA	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1186	29033130	PGK1	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1187	29033130	ESRRA	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1188	29033130	YAP1	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1189	29033130	FOXO1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1190	29033130	LILRB1	-0.7	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1191	29033130	UBA3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1192	29033130	PEF1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1193	29033130	SELE	-0.7	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1194	29033130	PTEN	-0.7	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1195	29033130	ST14	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1196	29033130	FASN	-9.3	0.226	0.645891560852599	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1197	29033130	PTK2	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1198	29033130	CTNNB1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1199	29033130	KDM1A	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1200	29033130	FGR	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1201	29033130	PCSK9	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1202	29033130	SELL	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1203	29033130	PARP1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1204	29033130	CXCL12	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1205	29033130	SH3PXD2A	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1206	29033130	MKI67	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1207	29033130	CD44	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1208	29033130	FGF4	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1209	29033130	FOLR2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1210	29033130	WNT11	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1211	29033130	LAG3	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1212	29033130	PTPN6	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1213	29033130	IRAK4	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1214	29033130	TUBA1B	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1215	29033130	DCLK1	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1216	29033130	GZMB	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1217	29033130	CEMIP	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1218	29033130	IGF1R	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1219	29033130	USP7	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1220	29033130	CCL22	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1221	29033130	ERBB2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1222	29033130	KRT17	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1223	29033130	ACLY	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1224	29033130	NBR1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1225	29033130	ITGB4	-18	0.0356	1.44855000202712	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1226	29033130	ROCK1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1227	29033130	PIK3C3	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1228	29033130	ICAM1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1229	29033130	SBSN	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1230	29033130	DNMT3A	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1231	29033130	ITGA4	-0.7	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1232	29033130	CXCR2	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1233	29033130	PDCD1	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1234	29033130	CD93	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1235	29033130	MRAP	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1236	29033130	COL6A1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1237	29033130	ATG7	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1238	29033130	CXCR6	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1239	29033130	CAMP	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1240	29033130	TIGIT	-20	0.0104	1.98296666070122	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1241	29033130	PIK3CB	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1242	29033130	SHOX2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1243	29033130	PPARGC1A	-20	0.0104	1.98296666070122	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1244	29033130	KDR	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1245	29033130	UCP1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1246	29033130	TLR2	-13.3	0.0505	1.29670862188134	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1247	29033130	GPM6A	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1248	29033130	IL13	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1249	29033130	HSPA4	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1250	29033130	PPP2CA	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1251	29033130	STC2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1252	29033130	EDN1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1253	29033130	EHMT2	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1254	29033130	HLA-DRA	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1255	29033130	TAP2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1256	29033130	TAP1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1257	29033130	CD109	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1258	29033130	ESR1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1259	29033130	AHR	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1260	29033130	HGF	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1261	29033130	ABCB1	-5.3	0.615	0.211124884224583	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1262	29033130	FGFR1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1263	29033130	RECQL4	-11.3	0.131	0.882728704344236	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1264	29033130	JAK2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1265	29033130	NOTCH1	3.3	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1266	29033130	AR	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1267	29033130	IRAK1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1268	29033130	DGKZ	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1269	29033130	RB1	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1270	29033130	CALM1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1271	29033130	WNT9B	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1272	29033130	NACC1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1273	29033130	IL1A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1274	29033130	FN1	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1275	29033130	WNT8A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1276	29033130	G3BP1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1277	29033130	UBR5	6	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1278	29033130	FOXP3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1279	29033130	BATF	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1280	29033130	SLC13A3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1281	29033130	CARD9	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1282	29033130	C1QC	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1283	29033130	WNT3A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1284	29033130	PRF1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1285	29033130	FOLH1	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1286	29033130	WNT10B	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1287	29033130	RIPK3	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1288	29033130	SLC7A5	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1289	29033130	NFATC1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1290	29033130	BMP2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1291	29033130	MMP9	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1292	29033130	C1QB	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1293	29033130	CD244	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1294	29033130	TRIM22	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1295	29033130	MRGPRX3	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1296	29033130	OLR1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1297	29033130	WNT1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1298	29033130	TPP2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1299	29033130	FOS	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1300	29033130	FTO	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1301	29033130	STAT5A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1302	29033130	ICAM2	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1303	29033130	KISS1R	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1304	29033130	CCL25	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1305	29033130	ROCK2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1306	29033130	CD8B	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1307	29033130	ARID5A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1308	29033130	STAT1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1309	29033130	MYBL2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1310	29033130	ADA	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1311	29033130	PABPC1L	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1312	29033130	NFATC2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1313	29033130	EOMES	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1314	29033130	WNT5A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1315	29033130	SGCB	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1316	29033130	NFKB1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1317	29033130	TERT	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1318	29033130	IRF4	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1319	29033130	VEGFA	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1320	29033130	NOD1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1321	29033130	EZH2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1322	29033130	NFX1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1323	29033130	CDCA8	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1324	29033130	HNF1A	-2.7	0.551	0.258848401148215	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1325	29033130	FGF21	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1326	29033130	CTLA4	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1327	29033130	WNT7A	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1328	29033130	ITGA2	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1329	29033130	IGF2R	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1330	29033130	TGFB2	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1331	29033130	ENTPD1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1332	29033130	SNHG1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1333	29033130	SPINT1	-4.7	0.411	0.386158178123931	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1334	29033130	SREBF1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1335	29033130	CD8A	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1336	29033130	ARHGAP10	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1337	29033130	POU5F1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1338	29033130	GPX2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1339	29033130	FGF2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1340	29033130	HLA-B	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1341	29033130	CXCR5	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1342	29033130	ONECUT3	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1343	29033130	CXCL9	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1344	29033130	PIK3CD	0	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1345	29033130	BACH2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1346	29033130	TREM2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1347	29033130	ZEB1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1348	29033130	PIK3R2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1349	29033130	FAP	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1350	29033130	TRIB3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1351	29033130	PRDM1	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1352	29033130	EBNA1BP2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1353	29033130	NES	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1354	29033130	PIKFYVE	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1355	29033130	CXCL10	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1356	29033130	IL2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1357	29033130	IDH1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1358	29033130	MAT1A	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1359	29033130	IFNGR1	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1360	29033130	SMARCA2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1361	29033130	CXCR3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1362	29033130	FASLG	4	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1363	29033130	NOS2	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1364	29033130	NOG	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1365	29033130	BSG	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1366	29033130	ATR	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1367	29033130	EIF4A3	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1368	29033130	IL15	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1369	29033130	IFNG	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1370	29033130	FNDC3B	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1371	29033130	PPP3CA	2	1	0	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1372	29033130	PPT1	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1373	29033130	WNT5B	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1374	29033130	CD47	-6.7	0.231	0.636388020107856	Bristol-Myers Squibb	Melanoma	Nivolumab	38	27	TISIDB	Mut_5
1375	29301960	SPP1	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1376	29301960	IGF2R	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1377	29301960	EPHA2	-10.7	0.365	0.437707135543525	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1378	29301960	NOTCH1	-10.7	0.365	0.437707135543525	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1379	29301960	PTK2	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1380	29301960	NOTCH4	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1381	29301960	PRKG1	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1382	29301960	VEGFA	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1383	29301960	LRP1B	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1384	29301960	LILRB1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1385	29301960	MTOR	-3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1386	29301960	MRGPRX3	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1387	29301960	ARID5A	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1388	29301960	UBR5	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1389	29301960	MYCN	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1390	29301960	KDR	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1391	29301960	ATG7	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1392	29301960	BCL2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1393	29301960	PANX1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1394	29301960	KMT2C	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1395	29301960	GPC3	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1396	29301960	SQSTM1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1397	29301960	AKT2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1398	29301960	PTEN	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1399	29301960	TNC	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1400	29301960	ANK3	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1401	29301960	RB1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1402	29301960	POLQ	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1403	29301960	MUC4	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1404	29301960	ITGB4	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1405	29301960	WNT9A	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1406	29301960	FN1	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1407	29301960	ITGB1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1408	29301960	MMP2	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1409	29301960	TAP1	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1410	29301960	HIF1A	10.7	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1411	29301960	ASCC3	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1412	29301960	ST14	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1413	29301960	JAG1	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1414	29301960	WNT2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1415	29301960	HDAC9	-3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1416	29301960	EZH2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1417	29301960	SPINT1	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1418	29301960	FASN	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1419	29301960	ANGPT2	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1420	29301960	PBX1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1421	29301960	EGF	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1422	29301960	CD8B	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1423	29301960	CPT1A	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1424	29301960	ITGB3	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1425	29301960	ABCB1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1426	29301960	IRF8	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1427	29301960	WNT10A	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1428	29301960	SMAD5	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1429	29301960	PIK3CD	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1430	29301960	PIK3R2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1431	29301960	MMP9	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1432	29301960	ITGA1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1433	29301960	SMARCA2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1434	29301960	AHR	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1435	29301960	CXCR3	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1436	29301960	TP53	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1437	29301960	CASP3	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1438	29301960	CISH	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1439	29301960	SREBF2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1440	29301960	POU2F1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1441	29301960	ACTA1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1442	29301960	NFATC2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1443	29301960	C1QC	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1444	29301960	ROCK1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1445	29301960	FOXP3	7.1	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1446	29301960	PIK3CG	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1447	29301960	DNMT3A	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1448	29301960	MAP4K1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1449	29301960	PARP1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1450	29301960	RGS1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1451	29301960	COL6A2	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1452	29301960	IL12B	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1453	29301960	SMAD4	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1454	29301960	PIKFYVE	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1455	29301960	DPP4	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1456	29301960	ROS1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1457	29301960	XBP1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1458	29301960	TNFSF10	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1459	29301960	ATR	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1460	29301960	TIMP1	-14.3	0.2	0.698970004336019	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1461	29301960	IRAK4	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1462	29301960	IGF1R	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1463	29301960	IDO1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1464	29301960	WNT5B	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1465	29301960	DDR1	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6
1466	29301960	PIK3CA	3.6	1	0	dbGap_phs001493.v1.p1	Clear cell renal cell carcinoma	Nivolumab	11	13	TISIDB	Mut_6